Trial Profile
A randomized, crossover study of K-877 in patients with dyslipidemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Nov 2016
Price :
$35
*
At a glance
- Drugs Pemafibrate (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- 29 Oct 2015 New trial record
- 29 Aug 2015